School of Medicine


Showing 31-40 of 62 Results

  • Niushen Zhang

    Niushen Zhang

    Clinical Associate Professor, Adult Neurology

    BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.

    Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University.

  • Ray Rui Zhang

    Ray Rui Zhang

    Adjunct Clinical Instructor, Radiology - Rad/Nuclear Medicine

    BioBackground:

    Ray Zhang grew up in Chicago, Illinois. He attended to UC Berkeley, where he majored in Chemical Biology. He then joined the Medical Scientist Training Program at the University of Wisconsin - Madison School of Medicine and Public Health, and earned his combined MD and PhD degrees. He completed his doctoral studies in the field of molecular imaging in the laboratories of Jamey Weichert and John Kuo, developing novel radiotracers for targeted cancer imaging and therapy.

    His career interest involves continued leadership, activism, and translational research in the area of molecular imaging and therapy.

    -------------------------------

    Education and Training:

    Stanford University Medical Center, Palo Alto CA
    Resident Physician, Department of Radiology (2020 - present)

    Loyola Medical Center, Maywood IL
    Resident Physician, Internal Medicine (6/2019-6/2020)

    University of Wisconsin, Madison WI
    M.D. (7/2011-5/2019)

    Ph.D. Cellular and Molecular Biology (8/2013 – 6/2017)
    Dissertation: Next Generation Alkylphosphocholine Analogs for Multimodality Imaging and Therapy of Cancer
    Advisor: Jamey Weichert, Ph.D., John Kuo, M.D., Ph.D., F.A.C.S.
    Project: Synthesis, characterization and preclinical imaging of tumor-targeted platform agents for intraoperative fluorescence-guided surgery, positron emission tomography, magnetic resonance imaging, and targeted radiotherapy

    University of California, Berkeley CA
    B.S., Highest Honors, Chemical Biology (2006 – 2009)
    William C. Braye Scholar 2006-2009

    ----------------------------------

    Honors and Leadership Positions:

    Lovell Memorial Scholarship for Excellence in Academic Radiology (2019)
    Department of Radiology, University of Wisconsin. Madison, WI

    Seminar Chair, Medical Scientist Training Program (2014-2015)
    University of Wisconsin. Madison, WI

    Keynote Speaker at Gray Matters Fundraiser Event
    Foundation in Support for Brain Cancer. Madison WI (2014)

    Secretary, Asian Pacific American Medical Student Association (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Treasurer, Asian Pacific American Medical Student Association (2012-2013)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Medical Scientist Training Program (2011-2019)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Co-founder, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Treasurer, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
    University of Wisconsin, School of Medicine and Public Health. Madison, WI

    Teaching Assitant/Mentorship Achievement Award in Biological Sciences (2014)
    Department of Cellular and Molecular Biology. University of Wisconsin-Madison

    SPARK Research Fellow, H. Lee Moffitt Cancer and Research Institute (2007-2008)
    Moffitt Cancer Center, Tampa, FL

    Highest Honors in Chemical Biology (2009)
    University of California, Berkeley

    Dean’s List (2006-2009)
    University of California, Berkeley

    William C. Braye Scholarship for Excellence in Chemistry (2006-2009)
    University of California, Berkeley

    --------------------------

    Publications/Patents:

    https://scholar.google.com/citations?user=yfG6A8MAAAAJ&hl=en

  • Tian Yi Zhang, MD, PhD

    Tian Yi Zhang, MD, PhD

    Assistant Professor of Medicine (Hematology)

    BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.

    In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.

    Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).

    She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.

    Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.

    She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.

    Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies.

  • Yu Zhang

    Yu Zhang

    Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.

    Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.

    The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases.